The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sleep Disorder Therapies Market Research Report 2025
Synopsis
Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
The global Sleep Disorder Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Therapies.
Report Scope
The Sleep Disorder Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleep Disorder Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep Disorder Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Phillips Healthcare
Nox Medical
Fisher and Paykel Healthcare
Responsive Surface Technology
Eight Sleep
Sleep Number
Vanda Pharmaceuticals
Eli Lilly
Neurim Pharmaceuticals
Merck
Segment by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Disorder Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.
The global Sleep Disorder Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Therapies.
Report Scope
The Sleep Disorder Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleep Disorder Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep Disorder Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Phillips Healthcare
Nox Medical
Fisher and Paykel Healthcare
Responsive Surface Technology
Eight Sleep
Sleep Number
Vanda Pharmaceuticals
Eli Lilly
Neurim Pharmaceuticals
Merck
Segment by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep Disorder Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep Disorder Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Insomnia
1.2.3 Excessive Sleep
1.2.4 Disturbed Sleep
1.3 Market by Application
1.3.1 Global Sleep Disorder Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapies Market Perspective (2019-2030)
2.2 Sleep Disorder Therapies Growth Trends by Region
2.2.1 Global Sleep Disorder Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sleep Disorder Therapies Historic Market Size by Region (2019-2024)
2.2.3 Sleep Disorder Therapies Forecasted Market Size by Region (2025-2030)
2.3 Sleep Disorder Therapies Market Dynamics
2.3.1 Sleep Disorder Therapies Industry Trends
2.3.2 Sleep Disorder Therapies Market Drivers
2.3.3 Sleep Disorder Therapies Market Challenges
2.3.4 Sleep Disorder Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapies Players by Revenue
3.1.1 Global Top Sleep Disorder Therapies Players by Revenue (2019-2024)
3.1.2 Global Sleep Disorder Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Sleep Disorder Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleep Disorder Therapies Revenue
3.4 Global Sleep Disorder Therapies Market Concentration Ratio
3.4.1 Global Sleep Disorder Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapies Revenue in 2023
3.5 Sleep Disorder Therapies Key Players Head office and Area Served
3.6 Key Players Sleep Disorder Therapies Product Solution and Service
3.7 Date of Enter into Sleep Disorder Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep Disorder Therapies Breakdown Data by Type
4.1 Global Sleep Disorder Therapies Historic Market Size by Type (2019-2024)
4.2 Global Sleep Disorder Therapies Forecasted Market Size by Type (2025-2030)
5 Sleep Disorder Therapies Breakdown Data by Application
5.1 Global Sleep Disorder Therapies Historic Market Size by Application (2019-2024)
5.2 Global Sleep Disorder Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sleep Disorder Therapies Market Size (2019-2030)
6.2 North America Sleep Disorder Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sleep Disorder Therapies Market Size by Country (2019-2024)
6.4 North America Sleep Disorder Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleep Disorder Therapies Market Size (2019-2030)
7.2 Europe Sleep Disorder Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sleep Disorder Therapies Market Size by Country (2019-2024)
7.4 Europe Sleep Disorder Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleep Disorder Therapies Market Size (2019-2030)
8.2 Asia-Pacific Sleep Disorder Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sleep Disorder Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Sleep Disorder Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleep Disorder Therapies Market Size (2019-2030)
9.2 Latin America Sleep Disorder Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sleep Disorder Therapies Market Size by Country (2019-2024)
9.4 Latin America Sleep Disorder Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleep Disorder Therapies Market Size (2019-2030)
10.2 Middle East & Africa Sleep Disorder Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sleep Disorder Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Sleep Disorder Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Sleep Disorder Therapies Introduction
11.1.4 Sanofi Revenue in Sleep Disorder Therapies Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Phillips Healthcare
11.2.1 Phillips Healthcare Company Detail
11.2.2 Phillips Healthcare Business Overview
11.2.3 Phillips Healthcare Sleep Disorder Therapies Introduction
11.2.4 Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2019-2024)
11.2.5 Phillips Healthcare Recent Development
11.3 Nox Medical
11.3.1 Nox Medical Company Detail
11.3.2 Nox Medical Business Overview
11.3.3 Nox Medical Sleep Disorder Therapies Introduction
11.3.4 Nox Medical Revenue in Sleep Disorder Therapies Business (2019-2024)
11.3.5 Nox Medical Recent Development
11.4 Fisher and Paykel Healthcare
11.4.1 Fisher and Paykel Healthcare Company Detail
11.4.2 Fisher and Paykel Healthcare Business Overview
11.4.3 Fisher and Paykel Healthcare Sleep Disorder Therapies Introduction
11.4.4 Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2019-2024)
11.4.5 Fisher and Paykel Healthcare Recent Development
11.5 Responsive Surface Technology
11.5.1 Responsive Surface Technology Company Detail
11.5.2 Responsive Surface Technology Business Overview
11.5.3 Responsive Surface Technology Sleep Disorder Therapies Introduction
11.5.4 Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2019-2024)
11.5.5 Responsive Surface Technology Recent Development
11.6 Eight Sleep
11.6.1 Eight Sleep Company Detail
11.6.2 Eight Sleep Business Overview
11.6.3 Eight Sleep Sleep Disorder Therapies Introduction
11.6.4 Eight Sleep Revenue in Sleep Disorder Therapies Business (2019-2024)
11.6.5 Eight Sleep Recent Development
11.7 Sleep Number
11.7.1 Sleep Number Company Detail
11.7.2 Sleep Number Business Overview
11.7.3 Sleep Number Sleep Disorder Therapies Introduction
11.7.4 Sleep Number Revenue in Sleep Disorder Therapies Business (2019-2024)
11.7.5 Sleep Number Recent Development
11.8 Vanda Pharmaceuticals
11.8.1 Vanda Pharmaceuticals Company Detail
11.8.2 Vanda Pharmaceuticals Business Overview
11.8.3 Vanda Pharmaceuticals Sleep Disorder Therapies Introduction
11.8.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2019-2024)
11.8.5 Vanda Pharmaceuticals Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Sleep Disorder Therapies Introduction
11.9.4 Eli Lilly Revenue in Sleep Disorder Therapies Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 Neurim Pharmaceuticals
11.10.1 Neurim Pharmaceuticals Company Detail
11.10.2 Neurim Pharmaceuticals Business Overview
11.10.3 Neurim Pharmaceuticals Sleep Disorder Therapies Introduction
11.10.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2019-2024)
11.10.5 Neurim Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Sleep Disorder Therapies Introduction
11.11.4 Merck Revenue in Sleep Disorder Therapies Business (2019-2024)
11.11.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sleep Disorder Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Insomnia
Table 3. Key Players of Excessive Sleep
Table 4. Key Players of Disturbed Sleep
Table 5. Global Sleep Disorder Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Sleep Disorder Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Sleep Disorder Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Sleep Disorder Therapies Market Share by Region (2019-2024)
Table 9. Global Sleep Disorder Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Sleep Disorder Therapies Market Share by Region (2025-2030)
Table 11. Sleep Disorder Therapies Market Trends
Table 12. Sleep Disorder Therapies Market Drivers
Table 13. Sleep Disorder Therapies Market Challenges
Table 14. Sleep Disorder Therapies Market Restraints
Table 15. Global Sleep Disorder Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Sleep Disorder Therapies Market Share by Players (2019-2024)
Table 17. Global Top Sleep Disorder Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapies as of 2023)
Table 18. Ranking of Global Top Sleep Disorder Therapies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Sleep Disorder Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sleep Disorder Therapies Product Solution and Service
Table 22. Date of Enter into Sleep Disorder Therapies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sleep Disorder Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Sleep Disorder Therapies Revenue Market Share by Type (2019-2024)
Table 26. Global Sleep Disorder Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Sleep Disorder Therapies Revenue Market Share by Type (2025-2030)
Table 28. Global Sleep Disorder Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Sleep Disorder Therapies Revenue Market Share by Application (2019-2024)
Table 30. Global Sleep Disorder Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Sleep Disorder Therapies Revenue Market Share by Application (2025-2030)
Table 32. North America Sleep Disorder Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Sleep Disorder Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Sleep Disorder Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Sleep Disorder Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Sleep Disorder Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Sleep Disorder Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Sleep Disorder Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Sleep Disorder Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Sleep Disorder Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Sleep Disorder Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Sleep Disorder Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Sleep Disorder Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Sleep Disorder Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Sleep Disorder Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Sleep Disorder Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Sleep Disorder Therapies Product
Table 50. Sanofi Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Phillips Healthcare Company Detail
Table 53. Phillips Healthcare Business Overview
Table 54. Phillips Healthcare Sleep Disorder Therapies Product
Table 55. Phillips Healthcare Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 56. Phillips Healthcare Recent Development
Table 57. Nox Medical Company Detail
Table 58. Nox Medical Business Overview
Table 59. Nox Medical Sleep Disorder Therapies Product
Table 60. Nox Medical Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 61. Nox Medical Recent Development
Table 62. Fisher and Paykel Healthcare Company Detail
Table 63. Fisher and Paykel Healthcare Business Overview
Table 64. Fisher and Paykel Healthcare Sleep Disorder Therapies Product
Table 65. Fisher and Paykel Healthcare Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 66. Fisher and Paykel Healthcare Recent Development
Table 67. Responsive Surface Technology Company Detail
Table 68. Responsive Surface Technology Business Overview
Table 69. Responsive Surface Technology Sleep Disorder Therapies Product
Table 70. Responsive Surface Technology Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 71. Responsive Surface Technology Recent Development
Table 72. Eight Sleep Company Detail
Table 73. Eight Sleep Business Overview
Table 74. Eight Sleep Sleep Disorder Therapies Product
Table 75. Eight Sleep Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 76. Eight Sleep Recent Development
Table 77. Sleep Number Company Detail
Table 78. Sleep Number Business Overview
Table 79. Sleep Number Sleep Disorder Therapies Product
Table 80. Sleep Number Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 81. Sleep Number Recent Development
Table 82. Vanda Pharmaceuticals Company Detail
Table 83. Vanda Pharmaceuticals Business Overview
Table 84. Vanda Pharmaceuticals Sleep Disorder Therapies Product
Table 85. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 86. Vanda Pharmaceuticals Recent Development
Table 87. Eli Lilly Company Detail
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Sleep Disorder Therapies Product
Table 90. Eli Lilly Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Neurim Pharmaceuticals Company Detail
Table 93. Neurim Pharmaceuticals Business Overview
Table 94. Neurim Pharmaceuticals Sleep Disorder Therapies Product
Table 95. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 96. Neurim Pharmaceuticals Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Sleep Disorder Therapies Product
Table 100. Merck Revenue in Sleep Disorder Therapies Business (2019-2024) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleep Disorder Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sleep Disorder Therapies Market Share by Type: 2023 VS 2030
Figure 3. Insomnia Features
Figure 4. Excessive Sleep Features
Figure 5. Disturbed Sleep Features
Figure 6. Global Sleep Disorder Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sleep Disorder Therapies Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Sleep Disorder Therapies Report Years Considered
Figure 12. Global Sleep Disorder Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Sleep Disorder Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Sleep Disorder Therapies Market Share by Region: 2023 VS 2030
Figure 15. Global Sleep Disorder Therapies Market Share by Players in 2023
Figure 16. Global Top Sleep Disorder Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Therapies as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Sleep Disorder Therapies Revenue in 2023
Figure 18. North America Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Sleep Disorder Therapies Market Share by Country (2019-2030)
Figure 20. United States Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Sleep Disorder Therapies Market Share by Country (2019-2030)
Figure 24. Germany Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Sleep Disorder Therapies Market Share by Region (2019-2030)
Figure 32. China Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Sleep Disorder Therapies Market Share by Country (2019-2030)
Figure 40. Mexico Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Sleep Disorder Therapies Market Share by Country (2019-2030)
Figure 44. Turkey Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Sleep Disorder Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 47. Phillips Healthcare Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 48. Nox Medical Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 49. Fisher and Paykel Healthcare Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 50. Responsive Surface Technology Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 51. Eight Sleep Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 52. Sleep Number Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 53. Vanda Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 54. Eli Lilly Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 55. Neurim Pharmaceuticals Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Sleep Disorder Therapies Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
